The vascular graft market was valued at USD 2.48 Billion in 2016 and is expected to reach USD 3.80 Billion by 2022, growing at a CAGR of 7.3% during the forecast period. The base year for this study is 2016 and the forecast period is 2017–2022.

The global vascular graft market is segmented by raw material, indication, end user, and regions. Based on raw material, the vascular grafts market is segmented into ePTFE grafts, polyester grafts, polyurethane grafts, and biosynthetic grafts. Polyester grafts are expected to dominate this market in 2017. Advantages such as the high patency, greater lifespan, and higher porosity of polyester grafts are majorly responsible for the high demand and adoption of polyester grafts among end users. This segment is also estimated to register the highest CAGR during the forecast period.

Drivers :
1 Growth in the Aging Population and the Associated Increase in the Prevalence of Aneurysm
2 Increasing Prevalence of Smoking
3 Increasing Incidence of ESRD
4 Growing Adoption of Minimally Invasive Surgeries

Restraint:
1.Product Failures and Recalls

PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=179457001

Opportunity:
1 Emerging Markets

Trend:
1 Development of Biosynthetic Vascular Grafts

The global vascular graft market is dominated by North America, followed by Europe. North America will continue to dominate the global vascular grafts market during the forecast period. Factors such as the rising government initiatives and increasing healthcare expenditure and increasing research and development in the field of vascular grafts research are driving the growth of the market in this region.

Market Key Players:

The major players operating in this market are B. Braun (Germany), C. R. Bard (US), Cardinal Health (US), Cook Medical (US), Endologix (US), LeMaitre Vascular (US), Medtronic (Ireland), Maquet (Germany), Terumo (Japan), and Gore Medical (US).

Know More: https://www.marketsandmarkets.com/Market-Reports/vascular-graft-market-179457001.html